Updated Date:
26 Mar 2026
Product Detail:
LECTEVA levodopa/carbidopa/entacapone 150 mg/37.5 mg/200 mg tablet bottle
Shortage Status:
Discontinued
AUST R:
238864
Availability:
Reduction in supply until supply is exhausted
Active Ingredient:
levodopa~entacapone~carbidopa monohydrate
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Tablet,filmcoated
Supply Impact Dates
Management Action:
Deletion from market: 15 Sep 2026
Availability: Reduction in supply until supply is exhausted
Management action: Alternative brands are available.